secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORASURE TECHNOLOGIES INC (OSUR)
CIK:        0001116463
Form:       8-K
Filed at:   2021-11-08T23:59:59+00:00
Accession:  0000950170-21-003312
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OraSure appoints Nancy Gagliano and Anne Whitaker to board of directors
-----------------------------------------------------------------------

- Board increased from nine to ten members; appointments effective November 8, 2021.
- Dr. Gagliano brings experience from NIH RADx program and CVS Health; will serve on Nominating & Corp Governance Committee.
- Ms. Whitaker brings pharma executive and public board experience; will serve on Audit Committee.
- Each received initial equity award of $105,000 in restricted shares vesting over two years.
- Both directors are independent under Nasdaq listing rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1116463/000095017021003312/0000950170-21-003312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1116463/000095017021003312/osur-20211107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-003312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer